Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys

被引:24
|
作者
Cournot, Maxime
Cambou, Jean-Pierre
Quentzel, Steven
Danchin, Nicolas
机构
[1] INSERM, U558, Dept Epidemiol, F-31073 Toulouse, France
[2] Bristol Myers Squibb Co, Rueil Malmaison, France
[3] Hop Europeen Georges Pompidou, Paris, France
关键词
statins; elderly; non-prescription; coronary heart disease; pharmaco-epidemiology; observance; tolerance;
D O I
10.1016/j.ijcard.2005.06.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The reasons why statins are under-utilized in elderly patients remain poorly understood. The aim of this study was to identify the reasons given by cardiologist for the non-prescription of statins in elderly CHD patients. Methods: Two cross-sectional pharmaco-epidemiological surveys were carried out among French cardiologists. The sample consisted of 1148 coronary patients aged 35 to 69 years and 1489 patients aged >= 70 years. Patients' risk factors, medical history, treatments, lipid values and the physicians' various motives for the non-prescription of statins were recorded. Results: Patients not treated with statins reached 37% in the age-group >= 70 years and 14% in the age-group 35-69 years. The main reason given for statin non-prescription was the lack of a medical indication (2.5% of the age-group 35 -69 years and 14% of the age-group < 70 years). Among patients >= 70 years, the lack of indication was more often cited in the following conditions: 1) in very old patients (36% of lack of indication in the age-group > 85 years vs. 10% in 70-75 years), 2) when lipid values were not available (20% when data were not available vs. 9%) and 3) when the patient had no prior history of myocardial infarction (MI) (20% when no history of MI vs. 7%). These factors were not associated with lack of indication among patients < 70 years. History of intolerance or side effect was given for 1.3% and 14% of patients for each of the groups (35-69 and > 70) and poor overall patient adherence was cited in 1% and 2%, respectively. Conclusion: The primary reason for the under-prescription of statins in elderly coronary patients is the perceived lack of indication, which stresses the need of extensive guidelines for prescription in elderly patients. Several factors associated with this perception seem to be specific to the elderly. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [1] Under-Prescription in Elderly Patients with Coronary Heart Disease - Data from the Salzburger Pharmakovigilanzzentrum (PVZ)
    Michalski, T.
    WeixIbaumer, H.
    Schuler, J.
    Hofer-Duckelmann, C.
    Prinz, E.
    BeindE, W.
    Pichler, M.
    JOURNAL FUR KARDIOLOGIE, 2011, 18 (9-10): : 308 - 311
  • [2] Under-prescription of statins in patients with non-alcoholic fatty liver disease
    Del Ben, M.
    Baratta, F.
    Polimeni, L.
    Pastori, D.
    Loffredo, L.
    Averna, M.
    Violi, F.
    Angelico, F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (02) : 161 - 167
  • [3] Statins Use in Elderly Patients with Coronary Heart Disease
    Zhai, M.
    Guo, Y. L.
    Wu, N. Q.
    Zhu, C. G.
    Dong, Q.
    Qing, P.
    Liu, G.
    Li, J. J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S334 - S334
  • [4] Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease
    Orenes-Pinero, Esteban
    Esteve-Pastor, Maria A.
    Ruiz-Nodar, Juan M.
    Quintana-Giner, Miriam
    Veliz-Martinez, Andrea
    Tello-Montoliu, Antonio
    Macias-Villanego, Manuel J.
    Pernias-Escrig, Vicente
    Vicente-Ibarra, Nuria
    Carrillo-Aleman, Luna
    Sandin-Rollan, Miriam
    Martinez, Juan
    Lozano, Teresa
    Rivera-Caravaca, Jose M.
    Marin, Francisco
    MINERVA MEDICA, 2019, 110 (05) : 410 - 418
  • [5] Paradoxical under-prescription of lipid-lowering therapy for secondary prevention of coronary heart disease in high-risk subjects
    Perdrix, J
    Mooser, V
    Darioli, R
    ATHEROSCLEROSIS, 1999, 144 : 72 - 72
  • [6] Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys
    De Bacquer, Dirk
    Astin, Felicity
    Kotseva, Kornelia
    Pogosova, Nana
    De Smedt, Delphine
    De Backer, Guy
    Ryden, Lars
    Wood, David
    Jennings, Catriona
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (02) : 383 - 395
  • [7] Inflammation markers are associated with frailty in elderly patients with coronary heart disease
    Hou, Ping
    Xue, Hui-Ping
    Mao, Xin-E
    Li, Yong-Nan
    Wu, Lin-Feng
    Liu, Yong-Bing
    AGING-US, 2018, 10 (10): : 2636 - 2645
  • [8] Factors associated with coronary heart disease in COPD patients and controls
    Svendsen, Christina D.
    Kuiper, Karel K. J.
    Ostridge, Kristoffer
    Larsen, Terje H.
    Nielsen, Rune
    Hodneland, Vidar
    Nordeide, Eli
    Bakke, Per S.
    Eagan, Tomas M.
    PLOS ONE, 2022, 17 (04):
  • [9] The Prevalence and Factors Associated with Coronary Heart Disease in Patients with Gout
    Markelova, E. L.
    Eliseev, M. S.
    Il'inykh, E. V.
    Glukhova, S. I.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2024, 517 (01) : 269 - 276
  • [10] THE PREVALENCE AND FACTORS ASSOCIATED WITH CORONARY HEART DISEASE IN PATIENTS WITH GOUT
    Markelova, E.
    Eliseev, M.
    Ilinykh, E.
    Glukhova, S.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1350 - 1350